Molecular and epidemiological characterization of IMP-Type metallo-β-lactamase-producing enterobacter cloacae in a large tertiary care hospital in Japan

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3441-3450

  Hayakawa, Kayoko ^a   Miyoshi Akiyama, Tohru ^a   Kirikae, Teruo ^a   Nagamatsu, Maki ^a   Shimada, Kayo ^a   Mezaki, Kazuhisa ^a   Sugiki, Yuko ^a   Kuroda, Emi ^a   Kubota, Shiho ^a   Takeshita, Nozomi ^a   Kutsuna, Satoshi ^a   Tojo, Masayoshi ^a   Ohmagari, Norio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; INOSINE PHOSPHATE; THIENAMYCIN DERIVATIVE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; FEMALE; HUMAN; INVASIVE PROCEDURE; JAPAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; VERY ELDERLY; YOUNG ADULT; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; HOSPITAL MORTALITY; INFECTION CONTROL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYLOGENY; R FACTOR; RISK FACTOR; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CEPHALOSPORINS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; IMIPENEM; INFECTION CONTROL; INOSINE MONOPHOSPHATE; JAPAN; MALE; MIDDLE AGED; PHYLOGENY; R FACTORS; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY HEALTHCARE; THIENAMYCINS;

EID: 84901264913     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02652-13     Document Type: Article

References (41)

1. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. http://dx.doi.org/10.1016/S1473-3099(08)70041-0.
2. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682-707. http://dx.doi.org/10.1128/CMR.05035-11.
3. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-betalactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381-393. http://dx.doi.org/10.1016/S1473-3099(11)70056-1.
4. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. 1994. Molecular characterization of an enterobac-terial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78. http://dx.doi.org/10.1128/AAC.38.1.71.
5. Castanheira M, Mendes RE, Rhomberg PR, Jones RN. 2008. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb. Drug Resist. 14:211-216. http://dx.doi.org/10.1089/mdr.2008.0827.
6. Fukigai S, Alba J, Kimura S, Iida T, Nishikura N, Ishii Y, Yamaguchi K. 2007. Nosocomial outbreak of genetically related IMP-1 beta-lactamaseproducing Klebsiella pneumoniae in a general hospital in Japan. Int. J. Antimicrob. Agents 29:306-310. http://dx.doi.org/10.1016/j.ijantimicag.2006.10.011.
7. Docquier JD, Riccio ML, Mugnaioli C, Luzzaro F, Endimiani A, Toniolo A, Amicosante G, Rossolini GM. 2003. IMP-12, a new plasmidencoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate. Antimicrob. Agents Chemother. 47:1522-1528. http://dx.doi.org/10.1128/AAC.47.5.1522-1528. 2003.
8. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A, Canton R. 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 16: 112-122. http://dx.doi.org/10.1111/j.1469- 0691.2009.03116.x.
9. Hamada Y, Watanabe K, Tatsuya T, Mezaki K, Takeuchi S, Shimizu T, Kirikae T, Ohmagari N. 2013. Three cases of IMP-type metallo-lactamase-producing Enterobacter cloacae bloodstream infection in Japan. J. Infect. Chemother. 19:956-958. http://dx.doi.org/10.1007/s10156-012-0520-6.
10. Dalben M, Varkulja G, Basso M, Krebs VL, Gibelli MA, van der Heijden I, Rossi F, Duboc G, Levin AS, Costa SF. 2008. Investigation of an outbreak of Enterobacter cloacae in a neonatal unit and review of the literature. J. Hosp. Infect. 70:7-14. http://dx.doi.org/10.1016/j.jhin.2008.05.003.
11. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686. http://dx.doi.org/10.1128/ CMR.18.4.657-686.2005.
12. Shet V, Gouliouris T, Brown NM, Turton JF, Zhang J, Woodford N. 2011. IMP metallo-beta-lactamase-producing clinical isolates of Enterobacter cloacae in the UK. J. Antimicrob. Chemother. 66:1408-1409. http://dx.doi.org/10.1093/jac/ dkr078.
13. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob. Agents Chemother. 52:1028-1033. http://dx.doi.org/10.1128/AAC.01020- 07.
14. Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, Pogue JM, Bheemreddy S, Blunden C, Shango M, Swan J, Lephart PR, Perez F, Bonomo RA, Kaye KS. 2012. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect. Control Hosp. Epidemiol. 33:817-830. http://dx.doi.org/10.1086/666642.
15. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. 2002. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin. Infect. Dis. 34:1558-1563. http://dx.doi.org/10.1086/340533.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. http://dx.doi.org/10.1016/0021-9681(87) 90171-8.
17. Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM. 1985. Validation of a prognostic score in critically ill patients undergoing transport. Br. Med. J. (Clin. Res. ed) 291:432-434. http://dx.doi.org/10.1136/bmj.291.6493.432.
18. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. 1963. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914-919. http://dx.doi.org/10.1001/jama.1963. 03060120024016.
19. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-Associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332. http://dx.doi.org/10.1016/j.ajic.2008.03.002.
20. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Approved standard M100-S19. CLSI, Wayne, PA.
21. Livermore DM, Warner M, Mushtaq S. 2007. Evaluation of the chromogenic Cica-beta-Test for detecting extended-spectrum,AmpCand metallo-beta-lactamases. J. Antimicrob. Chemother. 60:1375-1379. http://dx.doi.org/10.1093/jac/dkm374.
22. Kitao T, Miyoshi-Akiyama T, Tanaka M, Narahara K, Shimojima M, Kirikae T. 2011. Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo-beta-lactamases that mediate carbapenem resistance in Pseudomonas. J. Microbiol. Methods 87: 330-337. http://dx.doi.org/10.1016/j.mimet.2011.09.011.
23. The Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Approved standard M100-S22. CLSI, Wayne, PA.
24. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Fujino T, Kobayashi I, Morita K, Kikuchi Y, Kuratsuji T, Kirikae T. 2005. Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6=)-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrob. Agents Chemother. 49:3734-3742. http://dx.doi.org/10.1128/AAC.49.9. 3734-3742.2005.
25. Levesque C, Piche L, Larose C, Roy PH. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191. http://dx.doi.org/10.1128/AAC.39.1.185.
26. Miyoshi-Akiyama T, Hayakawa K, Ohmagari N, Shimojima M, Kirikae T. 2013. Multilocus sequence typing (MLST) for characterization of Enterobacter cloacae. PLoS One 8:e66358. http://dx.doi.org/10.1371/journal.pone.0066358.
27. European Committee on Antimicrobial Susceptibility Testing. 2013. Breakpoint tables for interpretation of MICs and zone diameters, version 3.1. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/ Breakpoint-table-v-3.1.pdf.
28. Hirakata Y, Yamaguchi T, Nakano M, Izumikawa K, Mine M, Aoki S, Kondoh A, Matsuda J, Hirayama M, Yanagihara K, Miyazaki Y, Tomono K, Yamada Y, Kamihira S, Kohno S. 2003. Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin. Infect. Dis. 37:26-32. http://dx.doi.org/10.1086/375594.
29. Pop-Vicas AE, D'Agata EM. 2005. The rising influx of multidrugresistant gram-negative bacilli into a tertiary care hospital. Clin. Infect. Dis. 40:1792-1798. http://dx.doi.org/10.1086/430314.
30. Qureshi ZA, Paterson DL, Peleg AY, Adams-Haduch JM, Shutt KA, Pakstis DL, Sordillo E, Polsky B, Sandkovsky G, Bhussar MK, Doi Y. 2012. Clinical characteristics of bacteraemia caused by extendedspectrum beta-lactamase- producing Enterobacteriaceae in the era of CTXM-type and KPC-type beta-lactamases. Clin. Microbiol. Infect. 18:887-893. http://dx.doi.org/10.1111/ j.1469-0691.2011.03658.x.
31. Herbert S, Halvorsen DS, Leong T, Franklin C, Harrington G, Spelman D. 2007. Large outbreak of infection and colonization with gram-negative pathogens carrying the metallo-beta-lactamase gene blaIMP-4 at a 320-bed tertiary hospital in Australia. Infect. Control Hosp. Epidemiol. 28:98-101. http://dx.doi.org/10. 1086/508841.
32. Nouer SA, Nucci M, de Oliveira MP, Pellegrino FL, Moreira BM. 2005. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob. Agents Chemother. 49:3663-3667. http://dx.doi.org/10.1128/AAC.49.9.3663-3667.2005.
33. Cornaglia G, Akova M, Amicosante G, Canton R, Cauda R, Docquier JD, Edelstein M, Frere JM, Fuzi M, Galleni M, Giamarellou H, Gniadkowski M, Koncan R, Libisch B, Luzzaro F, Miriagou V, Navarro F, Nordmann P, Pagani L, Peixe L, Poirel L, Souli M, Tacconelli E, Vatopoulos A, Rossolini GM, ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). 2007. Metallo-beta- lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380-388. http://dx.doi.org/10.1016/j. ijantimicag.2006.10.008.
34. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H. 2010. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin. Microbiol. Infect. 16:102-111. http://dx.doi.org/10.1111/j.1469- 0691.2009.03115.x.
35. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798. http://dx.doi.org/10.3201/eid1710.110655.
36. Yano H, Ogawa M, Endo S, Kakuta R, Kanamori H, Inomata S, Ishibashi N, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Kunishima H, Kitagawa M, Hirakata Y, Kaku M. 2012. High frequency of IMP-6 among clinical isolates of metallo-beta-lactamase-producing Escherichia coli in Japan. Antimicrob. Agents Chemother. 56:4554-4555. http://dx.doi.org/10.1128/AAC.00617-12.
37. Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Nakamura T, Wada Y, Orita T, Kofuku T, Yamasaki K, Sakamoto M, Kinoshita S, Aihara M, Arakawa Y. 2004. Metallo-beta-lactamase-producing gram-negative bacilli: laboratorybased surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J. Clin. Microbiol. 42:5256-5263. http://dx.doi.org/10.1128/JCM.42.11.5256-5263.2004.
38. Queenan AM, Bush K. 2007. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20:440-458. http://dx.doi.org/10.1128/CMR.00001-07.
39. Daikos GL, Panagiotakopoulou A, Tzelepi E, Loli A, Tzouvelekis LS, Miriagou V. 2007. Activity of imipenem against VIM-1 metallo-betalactamase- producing Klebsiella pneumoniae in the murine thigh infection model. Clin. Microbiol. Infect. 13:202-205. http://dx.doi.org/10.1111/j.1469-0691.2006.01590. x.
40. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, Georgousi K, Tzouvelekis LS, Tassios PT, Bamia C, Petrikkos G. 2009. Prospective observational study of the impact of VIM-1 metallobeta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob. Agents Chemother. 53:1868-1873. http://dx.doi.org/10.1128/AAC.00782- 08.
41. Mantengoli E, Luzzaro F, Pecile P, Cecconi D, Cavallo A, Attala L, Bartoloni A, Rossolini GM. 2011. Escherichia coli ST131 producing extended-spectrum beta-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options. Clin. Infect. Dis. 52:690-691. http://dx.doi.org/10.1093/ cid/ciq194